Daurismo 100 mg – DIN 02498480
Daurismo is Glasdegib Maleate 100 mg (tablet), sold in Canada. It is used for acute myeloid leukemia. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Glasdegib Maleate 100 mg
- Brand
- Daurismo
- Strength
- 100 mg
- Used for
- Acute myeloid leukemia
- Form
- Tablet
- Manufacturer
- Pfizer Canada ULC
- Drug class
- Hedgehog pathway inhibitor
- Sold in
- Canada
- DIN
- 02498480
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Glasdegib used for?
Glasdegib is used for acute myeloid leukemia.
- Medicine type
- Hedgehog pathway inhibitor
Official uses from the US prescribing label
DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.
From the FDA-approved label on DailyMed (published Dec 12, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02498480.
- It names Daurismo, Glasdegib Maleate 100 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Daurismo by Pfizer Canada ULC.
In Canada: prescription only.
Ingredients
Active: Glasdegib (Glasdegib Maleate)